Muthiah Vaduganathan

2008–2026 年に発表

433
論文数
40,139
被引用数
96
h 指数
384
i10 指数

被引用数

Muthiah Vaduganathan の年別被引用数1967 年: 被引用 1 件1994 年: 被引用 1 件1996 年: 被引用 2 件2000 年: 被引用 1 件2003 年: 被引用 3 件2005 年: 被引用 2 件2009 年: 被引用 6 件2010 年: 被引用 6 件2011 年: 被引用 4 件2012 年: 被引用 8 件2013 年: 被引用 21 件2014 年: 被引用 38 件2015 年: 被引用 56 件2016 年: 被引用 57 件2017 年: 被引用 78 件2018 年: 被引用 58 件2019 年: 被引用 453 件2020 年: 被引用 1,517 件2021 年: 被引用 1,477 件2022 年: 被引用 1,407 件2023 年: 被引用 1,703 件2024 年: 被引用 3,607 件2025 年: 被引用 2,578 件2026 年: 被引用 110 件1968〜1993 年は被引用が無いため表示していません1995 年は被引用が無いため表示していません1997〜1999 年は被引用が無いため表示していません2001〜2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません2006〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,257 件、この内訳の 20.3%イギリス: 引用元論文 1,579 件、この内訳の 7.5%中国: 引用元論文 1,435 件、この内訳の 6.8%イタリア: 引用元論文 1,239 件、この内訳の 5.9%ドイツ: 引用元論文 1,009 件、この内訳の 4.8%カナダ: 引用元論文 968 件、この内訳の 4.6%オランダ: 引用元論文 748 件、この内訳の 3.6%フランス: 引用元論文 675 件、この内訳の 3.2%スペイン: 引用元論文 584 件、この内訳の 2.8%オーストラリア: 引用元論文 569 件、この内訳の 2.7%日本: 引用元論文 552 件、この内訳の 2.6%スウェーデン: 引用元論文 478 件、この内訳の 2.3%
0%20.3%その他 32.9%

分野

  • Medicine86.6%
  • Biochemistry, Genetics and Molecular Biology4.7%
  • Health Professions1.4%
  • Engineering1.4%
  • Computer Science1%
  • Immunology and Microbiology0.7%
  • その他4.2%

トピック

  • Heart Failure Treatment and Management9.9%
  • Cardiovascular Function and Risk Factors7.3%
  • Diabetes Treatment and Management6.7%
  • COVID-19 Clinical Research Studies3.6%
  • Cardiac pacing and defibrillation studies1.9%
  • Acute Myocardial Infarction Research1.8%
  • その他68.8%

共著者

全論文

検索で開く
  1. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde - New England Journal of Medicine 2022 被引用: 2,658

  2. The Global Burden of Cardiovascular Diseases and Risk

    著者: , , , , - Journal of the American College of Cardiology 2022 被引用: 2,077

  3. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brendon L. Neuen, Milton Packer, Vlado Perkovic, Marc S. Sabatine, Scott D. Solomon, Muthiah Vaduganathan, Christoph Wanner, David C. Wheeler, Stephen D. Wiviott, Faı̈ez Zannad - The Lancet 2022 被引用: 974

  4. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

    著者: , , , , , , , , , , , , , - The Lancet 2022 被引用: 916

  5. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Cardiac Failure 2023 被引用: 656

  6. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gustavs Latkovskis, Alex Pui‐Wai Lee, Gerard C.M. Linssen, Guillermo Llamas-Esperón, Vyacheslav Mareev, Felipe A. Martínez, Vojtěch Melenovský, Béla Merkely, Savina Nodari, Mark C. Petrie, Clara Saldarriaga, José Francisco Kerr Saraiva, Naoki Sato, Morten Schou, Kavita Sharma, Richard W. Troughton, Jacob A. Udell, Heikki Ukkonen, Orly Vardeny, Subodh Verma, Dirk von Lewinski, Л. Г. Воронков, Mehmet Birhan Yılmaz, Shelley Zieroth, James Lay‐Flurrie, Ilse van Gameren, Flaviana Amarante, Peter Kolkhof, Prabhakar Viswanathan - New England Journal of Medicine 2024 被引用: 709

  7. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020

    著者: , , - JAMA 2024 被引用: 422

  8. Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

    著者: , , , , , , , , , , , , , , , - Circulation 2023 被引用: 300

  9. Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

    著者: , , , , , , , , , , , , - JAMA Cardiology 2023 被引用: 250

  10. The Global Health and Economic Burden of Hospitalizations for Heart Failure

    著者: , , , , , , , , , , - Journal of the American College of Cardiology 2014 被引用: 2,028

  11. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction

    著者: , , , , , , , , , , - Circulation 2019 被引用: 775

  12. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2019 被引用: 537

  13. Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC

    著者: , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2023 被引用: 227

  14. Dapagliflozin for heart failure according to body mass index: the DELIVER trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2022 被引用: 146

  15. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

    著者: , , , , , , , , , - The Lancet 2020 被引用: 649

  16. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amir Kasaeian, André Pascal Kengne, Abdur Rahman Khan, Adnan Kısa, Sezer Kısa, Dhaval Kolte, Navid Manafi, Amir Manafi, George A. Mensah, Erkin М Мirrakhimov, Yousef Mohammad, Ali H. Mokdad, Ruxandra Irina Negoi, Huong Lan Thi Nguyen, Trang Huyen Nguyen, Molly R Nixon, Catherine M Otto, Shanti Patel, Thomas Pilgrim, Amir Radfar, David Laith Rawaf, Salman Rawaf, Wasiq Faraz Rawasia, Aziz Rezapour, Leonardo Roever, Anas M. Saad, Seyedmohammad Saadatagah, Subramanian Senthilkumaran, Karen Sliwa, Berhe Etsay Tesfay, Bach Xuan Tran, Irfan Ullah, Muthiah Vaduganathan, Tommi Vasankari, Charles Wolfe, Naohiro Yonemoto, Gregory A. Roth, For the Global Burden of Disease Study 2017 Nonrheumatic Valve Disease Collaborators - Circulation 2020 被引用: 473

  17. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 275

  18. Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction

    著者: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 被引用: 486

  19. Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2024 被引用: 136

  20. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2024 被引用: 165

  21. Screening and Management of Depression in Patients With Cardiovascular Disease

    著者: , , , , - Journal of the American College of Cardiology 2019 被引用: 349

  22. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations

    著者: , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 被引用: 136

  23. Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 被引用: 150

  24. SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction

    著者: , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2023 被引用: 101